The activation of c-Jun NH2-terminal kinase is required for dihydroartemisinin-induced autophagy in pancreatic cancer cells

Journal of Experimental and Clinical Cancer Research

Volumn 33, Issue 1, 2014, Pages

  Jia, Guang ^a   Kong, Rui ^a   Ma, Zhi Bin ^a   Han, Bing ^a   Wang, Yong Wei ^a   Pan, Shang Ha ^a   Li, Ying Hua ^a   Sun, Bei ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Autophagy; Beclin 1; c Jun NH2 terminal kinase; Dihydroartemisinin; LC3; Pancreatic cancer

Indexed keywords

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; ARTEMISININS; AUTOPHAGY; CASPASE 3; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME ACTIVATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MEMBRANE PROTEINS; PANCREATIC NEOPLASMS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; REACTIVE OXYGEN SPECIES;

EID: 84892473066     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-33-8     Document Type: Article

References (48)

1. Acetylcholinesterase expression mediated by c-Jun-NH2-terminal kinase pathway during anticancer drug-induced apoptosis. Deng R, Li W, Guan Z, Zhou JM, Wang Y, Mei YP, Li MT, Feng GK, Huang W, Liu ZC, Han Y, Zeng YX, Zhu XF, Oncogene 2006 25 7070 7077 10.1038/sj.onc.1209686 16715131 (Pubitemid 44722074)
2. Effect of ulinastatin on growth inhibition, apoptosis of breast carcinoma cells is related to a decrease in signal conduction of JNk-2 and NF-κB. Wang H, Sun X, Gao F, Zhong B, Zhang YH, Sun Z, J Exp Clin Cancer Res 2012 31 2 10.1186/1756-9966-31-2 22217202
3. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Kuan CY, Yang DD, Samanta Roy DR, Davis RJ, Rakic P, Flavell RA, Neuron 1999 22 667 676 10.1016/S0896-6273(00) 80727-8 10230788 (Pubitemid 29203491)
4. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davis RJ, Science 2000 288 870 874 10.1126/science.288.5467.870 10797012 (Pubitemid 30257738)
5. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Yang DD, Kuan CY, Whitmarsh AJ, Rincon M, Zheng TS, Davis RJ, Rakic P, Flavell RA, Nature 1997 389 865 870 10.1038/39899 9349820 (Pubitemid 27462982)
6. A critical role of neural-specific JNK3 for ischemic apoptosis. Kuan CY, Whitmarsh AJ, Yang DD, Liao G, Schloemer AJ, Dong C, Bao J, Banasiak KJ, Haddad GG, Flavell RA, Davis RJ, Rakic P, Proc Natl Acad Sci 2003 100 15184 15189 10.1073/pnas.2336254100 14657393 (Pubitemid 37518037)
7. Deletion of the c-Jun N-terminal kinase 3 gene protects neonatal mice against cerebral hypoxic-ischaemic injury. Pirianov G, Brywe KG, Mallard C, Edwards AD, Flavell RA, Hagberg H, Mehmet H, J Cereb Blood Flow Metab 2007 27 1022 1032 17063149 (Pubitemid 46659033)
8. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME, Science 1995 270 1326 1331 10.1126/science.270.5240.1326 7481820
9. The JNK signal transduction pathway. Weston CR, Davis RJ, Curr Opin Cell Biol 2007 19 142 149 10.1016/j.ceb.2007.02.001 17303404 (Pubitemid 46386399)
10. Multisite phosphorylation regulates Bim stability and apoptotic activity. Hubner A, Barrett T, Flavell RA, Davis RJ, Mol Cell 2008 30 415 425 10.1016/j.molcel.2008.03.025 18498746 (Pubitemid 351672377)
11. Mcl-1 integrates the opposing actions of signaling pathways that mediate survival and apoptosis. Morel C, Carlson SM, White FM, Davis RJ, Mol Cell Biol 2009 29 3845 3852 10.1128/MCB.00279-09 19433446
12. Functional cooperation of the proapoptotic Bcl2 family proteins Bmf and Bim in vivo. Hubner A, Cavanagh-Kyros J, Rincon M, Flavell RA, Davis RJ, Mol Cell Biol 2010 30 98 105 10.1128/MCB.01155-09 19841067
13. Activation of C-jun N-terminal kinase/stress-activated protein kinase in primary glial cultures. Zhang P, Miller BS, Rosenzweig SA, Bhat NR, J Neurosci Res 1996 46 114 121 10.1002/(SICI)1097-4547(19961001)46:1<114::AID- JNR14>3.0.CO;2-5 8892112 (Pubitemid 26330585)
14. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, Huang TT, Bos JL, Medema RH, Burgering BM, Nature 2002 419 316 321 10.1038/nature01036 12239572
15. Renal cancer-selective Englerin A induces multiple mechanisms of cell death and autophagy. Williams RT, Yu AL, Diccianni MB, Theodorakis EA, Batova A, J Exp Clin Cancer Res 2013 32 57 10.1186/1756-9966-32-57 23958461
16. Control of autophagy by oncogenes and tumor suppressor genes. Maiuri MC, Tasdemir E, Criollo A, Morselli E, Vicencio JM, Carnuccio R, Kroemer G, Cell Death Differ 2009 16 87 93 10.1038/cdd.2008.131 18806760
17. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z, EMBO J 2007 26 1749 1760 10.1038/sj.emboj.7601623 17347651 (Pubitemid 46624042)
18. Regulation of autophagy by ROS: physiology and pathology. Scherz-Shouval R, Elazar Z, Trends Biochem Sci 2011 36 30 38 10.1016/j.tibs.2010.07.007 20728362
19. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, Mukherjee C, Shi Y, Gélinas C, Fan Y, Nelson DA, Jin S, White E, Cancer Cell 2006 10 51 64 10.1016/j.ccr.2006.06.001 16843265
20. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, Levine B, Nature 1999 402 672 676 10.1038/45257 10604474 (Pubitemid 129516338)
21. Development by self-digestion: Molecular mechanisms and biological functions of autophagy. Levine B, Klionsky DJ, Dev Cell 2004 6 463 477 10.1016/S1534-5807(04)00099-1 15068787 (Pubitemid 38456176)
22. Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network. Kihara A, Kabeya Y, Ohsumi Y, Yoshimori T, EMBO Rep 2001 2 330 335 10.1093/embo-reports/kve061 11306555 (Pubitemid 32401529)
23. The Beclin 1 network regulates autophagy and apoptosis. Kang R, Zeh HJ, Lotze MT, Tang D, Cell Death and Differ 2011 18 571 580 10.1038/cdd.2010.191
24. Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. Liang XH, Kleeman LK, Jiang HH, Gordon G, Goldman JE, Berry G, Herman B, Levine B, J Virol 1998 72 8586 8596 9765397 (Pubitemid 28471796)
25. Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo. Disbrow GL, Baege AC, Kierpiec KA, Yuan H, Centeno JA, Thibodeaux CA, Hartmann D, Schlegel R, Cancer Res 2005 65 10854 10861 10.1158/0008-5472.CAN-05-1216 16322232 (Pubitemid 41713353)
26. The role of heme and the mitochondrion in the chemical and molecular mechanisms of mammalian cell death induced by the artemisinin antimalarials. Mercer AE, Copple IM, Maggs JL, O'Neill PM, Park BK, J Biol Chem 2011 286 987 996 10.1074/jbc.M110.144188 21059641
27. Dihydroartemisinin induces apoptosis by a Bak-dependent intrinsic pathway. Handrick R, Ontikatze T, Bauer KD, Freier F, Rübel A, Dürig J, Belka C, Jendrossek V, Mol Cancer Ther 2010 9 2497 2510 10.1158/1535-7163. MCT-10-0051 20663933
28. Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action. Hou J, Wang D, Zhang R, Wang H, Clin Cancer Res 2008 14 5519 5530 10.1158/1078-0432.CCR-08-0197 18765544
29. The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells. Li DD, Wang LL, Deng R, Tang J, Shen Y, Guo JF, Wang Y, Xia LP, Feng GK, Liu QQ, Huang WL, Zeng YX, Zhu XF, Oncogene 2009 28 886 898 10.1038/onc.2008.441 19060920
30. The role of autophagy in cancer development and response to therapy. Kondo Y, Kanzawa T, Sawaya R, Kondo S, Nat Rev Cancer 2005 5 726 734 10.1038/nrc1692 16148885 (Pubitemid 41486365)
31. DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. Katayama M, Kawaguchi T, Berger MS, Pieper RO, Cell Death Differ 2007 14 548 558 10.1038/sj.cdd.4402030 16946731
32. Autophagy is activated for cell survival after endoplasmic reticulum stress. Ogata M, Hino S, Saito A, Morikawa K, Kondo S, Kanemoto S, Murakami T, Taniguchi M, Tanii I, Yoshinaga K, Shiosaka S, Hammarback JA, Urano F, Imaizumi K, Mol Cell Biol 2006 26 9220 9231 10.1128/MCB.01453-06 17030611 (Pubitemid 44904418)
33. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Wei Y, Pattingre S, Sinha S, Bassik M, Levine B, Mol Cell 2008 30 678 688 10.1016/j.molcel.2008.06.001 18570871 (Pubitemid 351818252)
34. Autophagic cell death: the story of a misnomer. Kroemer G, Levine B, Nat Rev Mol Cell Biol 2008 9 1004 1010 10.1038/nrm2529 18971948
35. Inhibition of macroautophagy triggers apoptosis. Boya P, Gonzalez-Polo RA, Casares N, Perfettini JL, Dessen P, Larochette N, Métivier D, Meley D, Souquere S, Yoshimori T, Pierron G, Codogno P, Kroemer G, Mol Cell Biol 2005 25 1025 1040 10.1128/MCB.25.3.1025-1040.2005 15657430 (Pubitemid 40165810)
36. Suppression of autophagy enhances preferential toxicity of paclitaxel to folliculin-deficient renal cancer cells. Zhang Q, Si S, Schoen S, Chen J, Jin XB, Wu G, J Exp Clin Cancer Res 2013 32 99 10.1186/1756-9966-32-99 24305604
37. Loss of macroautophagy promotes or prevents fibroblast apoptosis depending on the death stimulus. Wang Y, Singh R, Massey AC, Kane SS, Kaushik S, Grant T, Xiang Y, Cuervo AM, Czaja MJ, J Biol Chem 2008 283 4766 4777 18073215
38. Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo. Wang SJ, Gao Y, Chen H, Kong R, Jiang HC, Pan SH, Xue DB, Bai XW, Sun B, Cancer Lett 2010 293 99 108 10.1016/j.canlet.2010.01.001 20137856
39. Regulation of autophagy through multiple independent hypoxic signaling pathways. Rouschop KM, Wouters BG, Curr Mol Med 2009 9 417 424 10.2174/156652409788167131 19519399
40. Autophagy inhibition sensitizes colon cancer cells to anti-angiogenic and cytotoxic therapy. Selvakumaran M, Amaravadi R, Vasilevskaya IA, O'Dwyer PJ, Clin Cancer Res 2013 19 2995 3007 10.1158/1078-0432.CCR-12-1542 23461901
41. Targeting autophagy augments in vitro and in vivo antimyeloma activity of DNA-damaging chemotherapy. Pan Y, Gao Y, Chen L, Gao G, Dong H, Yang Y, Dong B, Chen X, Clin Cancer Res 2011 17 3248 3258 10.1158/1078-0432.CCR-10-0890 21288924
42. High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy. Gonzalez-Malerva L, Park J, Zou L, Hu Y, Moradpour Z, Pearlberg J, Sawyer J, Stevens H, Harlow E, LaBaer J, Proc Natl Acad Sci USA 2011 108 2058 2063 10.1073/pnas.1018157108 21233418
43. Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Apel A, Herr I, Schwarz H, Rodemann HP, Mayer A, Cancer Res 2008 68 1485 1494 10.1158/0008-5472.CAN-07-0562 18316613 (Pubitemid 351346857)
44. Oxidant-induced hepatocyte injury from menadione is regulated by ERK and AP-1 signaling. Czaja MJ, Liu H, Wang Y, Hepatology 2003 37 1405 1413 10.1053/jhep.2003.50233 12774020 (Pubitemid 36667321)
45. Hepatocyte resistance to oxidative stress is dependent on protein kinase C-mediated down-regulation of c-Jun/AP-1. Wang Y, Schattenberg JM, Rigoli RM, Storz P, Czaja MJ, J Biol Chem 2004 279 31089 31097 10.1074/jbc.M404170200 15145937 (Pubitemid 39037770)
46. NF-κB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun. Liu H, Lo CR, Czaja MJ, Hepatology 2002 35 772 778 10.1053/jhep.2002.32534 11915022 (Pubitemid 34258370)
47. JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE, Czaja MJ, Hepatology 2006 43 163 172 10.1002/hep.20999 16374858 (Pubitemid 43733603)
48. Mitochondrial BCL-2 inhibits AMBRA1-induced autophagy. Strappazzon F, Vietri-Rudan M, Campello S, Nazio F, Florenzano F, Fimia GM, Piacentini M, Levine B, Cecconi F, EMBO J 2011 30 1195 1208 10.1038/emboj.2011.49 21358617